« Back
Home /
Taurodeoxycholic acid sodium hydrate

Taurodeoxycholic acid sodium hydrate

Item no.	TMO-TJA2398-50mg
Manufacturer	TargetMol
CASRN	110026-03-4
Amount	50 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 20 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	98.00%
Citations	Roda A , Piazza F , Baraldini M , et al. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat[J]. Hepatology, 1998, 27.
Smiles	C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(NCCS(=O)([O-])=O)=O)([H])[C@@]3([H])[C@@](C[C@@H]1O)([H])[C@@]4([C@](C[C@@H](CC4)O)([H])CC3)C.[Na+].O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Sodium taurodeoxycholate monohydrate,Taurodeoxychloic Acid sodium hydrate,Taurohyodeoxycholic acid sodium salt
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|Caspase
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	539.7
Description	Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate), a hydrophilic bile salt, influences bile salt and biliary lipid secretion in rats.
Pathways	Proteases/Proteasome\|\|\|Apoptosis
Bioactivity	Taurohyodeoxycholic acid sodium salt, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat.
Receptor	Caspase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-TJA2398-50mg-datasheet.pdf

TMO-TJA2398-50mg-safety-datasheet.pdf